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Abstract Endometrial polyps, submucous fibroids, uterine
septa, and intrauterine adhesions can be found by ultrasound
(US), HSG, hysteroscopy, or any combined in 10–15 % of
infertile women. Observational studies suggest a better re-
productive outcome when these anomalies are removed by
operative hysteroscopy. The current Cochrane review as-
sesses the effectiveness of hysteroscopy for treating these
suspected anomalies in women with otherwise unexplained
infertility or prior to intrauterine insemination, in vitro fer-
tilization, or intracytoplasmic sperm injection.
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Background
Endometrial polyps, submucous fibroids, uterine septa, and
intrauterine adhesions can be found by ultrasound (US),
HSG, hysteroscopy, or any combined in 10–15 % of infertile
women. Observational studies suggest a better reproductive
outcome, when these anomalies are removed by operative
hysteroscopy. The current Cochrane review assesses the
effectiveness of hysteroscopy for treating these suspected
anomalies in women with otherwise unexplained infertility
or prior to intrauterine insemination (IUI), in vitro fertilization
(IVF), or intracytoplasmic sperm injection (ICSI) [1].
Methods
We searched electronic databases including CENTRAL (The
Cochrane Library 2012, Issue 7), MEDLINE (1950 to
27 October 2012), and EMBASE (1974 to 27 October 2012)
conference proceedings from the American Society for Repro-
ductive Medicine through hand searching (from 2008 to 30
October 2012) and reference lists of retrieved articles. Eligible
reports were parallel-design randomized trials (RCTs), compar-
ing operative hysteroscopy with a control intervention in wom-
en with suspected uterine cavity abnormalities and otherwise
unexplained infertility or undergoing IUI, IVF, or ICSI. The
primary outcomes were live birth and hysteroscopy complica-
tion rates. Secondary outcomes were ongoing or clinical preg-
nancy and miscarriage rates. We expressed the dichotomous
outcome measures as Mantel–Haenszel odds ratios (ORs) with
95 % confidence intervals (CIs) using a fixed-effect model.
Results
Trial quality
Only two studies met the eligibility criteria for inclusion in the
review. One study included 94 women with otherwise
unexplained infertility and not more than two submucous
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fibroids or one submucous fibroid combined with one intra-
mural fibroid, all smaller than 40 mm [2]. The second trial [5]
assessed the effectiveness of the hysteroscopic removal of
endometrial polyps with a mean diameter of 16 mm diagnosed
by Doppler US in 215 women bound to undergo gonadotropin
treatment and IUI for unexplained, male or female factor
infertility for at least 2 years. Both trials used computer-
generated random number tables; in only one allocation con-
cealment was adequate [5]. Blinding of patients, personnel,
and outcome assessors was not assessed because these items
are less relevant in the setting of a surgical trial with unequiv-
ocal outcomes and a long follow-up period. Both studies were
at low risk for attrition bias but had some potential for selective
outcome reporting; no data for live birth rates were available
despite long follow up periods of 86 [2] and 50 months [5].We
could not do a formal assessment of publication bias, since
only two RCTs were included in the current review.
Primary outcomes: live birth and hysteroscopy complication
rates
We retrieved no data for all primary outcomes.
Secondary outcomes
Clinical pregnancy rates
Removal of not more than two submucous fibroids or one
submucous fibroid combined with one intramural fibroid, all
smaller than 40mm, in women with unexplained infertility for
at least 1 year tends to increase the odds of clinical pregnancy
compared to regular fertility-oriented intercourse. The differ-
ences between both comparison groups fail to reach statistical
significance (OR 2.4, 95 % CI 0.97–6.2) (Fig. 1). Our results
are not in accordance with the calculation of the authors in the
primary study report; they reported statistically significant
differences between both comparison groups both in women
with not more than two submucous fibroids only or one
submucous combined with one intramural fibroid [2].
The hysteroscopic removal of endometrial polyps with a
mean size of 16 mm increases the odds of clinical pregnancy
prior to IUI for unexplained male or female factor infertility
for at least 2 years, compared to diagnostic hysteroscopy
and polyp biopsy only (OR 4.4, 95 % CI 2.5–8.0).
Miscarriage rates
There is no evidence for differences in the miscarriage rates
after the hysteroscopic removal of not more than two
submucous fibroids or one submucous fibroid with one
intramural fibroid in women with otherwise unexplained
infertility for at least 1 year, compared to regular fertility-
oriented intercourse (OR 1.5, 95 % CI 0.47–5.00).
Conclusions
The only randomized study published in the literature on the
hysteroscopic removal of fibroids in infertile women has
claimed statistically significant differences in the clinical
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Fig. 1 Forest plot of comparison: 1 Hysteroscopic myomectomy vs. regular fertility-oriented intercourse in women with unexplained subfertility and not
more than two submucous fibroids or one submucous fibroid combinedwith one intramural fibroid, all smaller than 40mm.Outcome: 1.1Clinical pregnancy
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pregnancy rates between both comparison groups. Our own
recalculation of the available data fails to demonstrate sta-
tistically significant differences. This statistical error raises
concerns about the validity of the published primary data.
Moreover, we judged the overall study quality study to be very
low. This has implications for clinical research; additional
RCTs studying the effectiveness of hysteroscopic myomecto-
my in infertile women are needed. The implications for daily
practice are more controversial. The gynecological profession
widely accepts that submucosal and intramural fibroids inter-
fere with fertility in decreasing order of importance based on
the results and conclusions of a large systematic literature
review with a meta-analysis of observational studies [6, 7].
While conservative, medical, and surgical treatment are all
considered as being appropriate for treating symptomatic fi-
broids, myomectomy seems the only reasonable treatment
option for women who wish to become pregnant. Women
treated by hysteroscopic myomectomy for submucosal fibroids
might have similar reproductive outcomes as infertile women
with normal uterine cavities [8]. According to one prospective
study, the surgical removal of large intramural fibroids in
women with otherwise unexplained infertility prior to IVF
treatment might increase the likelihood of a successful repro-
ductive outcome [4]. Our critical appraisal of the current evi-
dence supports the conclusion published by others in the recent
past; at the present, there is still evidence of uncertainty on the
effectiveness of removing fibroids in infertile women [3].
The hysteroscopic removal of endometrial polyps in
women bound to undergo IUI for unexplained, male, or
female factor infertility for at least 24 months increases the
odds of clinical pregnancy compared to diagnostic hyster-
oscopy and biopsy only. The level of evidence of this single
study was graded as high.
More well-designed pragmatic RCTs are needed to assess
the effectiveness of the hysteroscopic removal of endometrial
polyps, submucous fibroids, uterine septa, or intrauterine ad-
hesions in women with otherwise unexplained infertility or
prior to IUI, ICSI, or IVF, preferably measuring live birth and
adverse events as primary outcomes. The effects of the num-
ber, size, and location of the intrauterine pathology as well as
the relationship between the timing of the hysteroscopy and
subsequent fertility treatment should be addressed by
predefined and sensible subgroup analyses.
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